Neuphoria Therapeutics Inc. (NEUP) Net income 2023–2026
Neuphoria Therapeutics Inc. (NEUP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$13.5MFY2026 · since FY2023: -$21.4M → -$13.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$13.5M | -3539.3% |
| FY2025 | -$369,632 | +97.6% |
| FY2024 | -$15.5M | +27.5% |
| FY2023 | -$21.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NEUP financial trends
NEUP RevenueNEUP Net marginNEUP Gross profitNEUP Gross marginNEUP Operating incomeNEUP Operating marginNEUP Operating cash flowNEUP Free cash flowNEUP Capital expendituresNEUP Return on equityNEUP Stock buybacksNEUP Dividends paidNEUP Total assetsNEUP Total liabilitiesNEUP Shareholders’ equityNEUP overview →